Section of Cardiac Surgery, Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, AB, Canada.
Health Technology & Policy Unit (HTPU), School of Public Health, University of Alberta, Edmonton, AB, Canada.
Innovations (Phila). 2022 Nov-Dec;17(6):471-481. doi: 10.1177/15569845221141488. Epub 2022 Dec 18.
Robot-assisted surgery is a minimally invasive approach for repairing the mitral valve. This study aimed to assess its safety and clinical efficacy when compared with conventional sternotomy, partial sternotomy, and right minithoracotomy.
A systematic review of peer-reviewed studies comparing robot-assisted mitral valve repair with conventional sternotomy, partial sternotomy, and right minithoracotomy was conducted following Cochrane Collaboration guidelines. Meta-analyses were performed where possible.
The search strategy yielded 15 primary studies, of which 12 compared robot-assisted with conventional sternotomy, 2 compared robot-assisted with partial sternotomy, and 6 compared robot-assisted with right minithoracotomy. The overall quality of evidence was low, and there was a lack of data on long-term outcomes. Individual studies and pooled data demonstrated that robotic procedures were comparable to conventional sternotomy and other minimally invasive approaches with respect to the rates of stroke, renal failure, reoperation for bleeding, and mortality. Robot-assisted mitral valve repair was superior to conventional sternotomy with reduced atrial fibrillation, intensive care unit and hospital stay, pain, time to return to normal activities, and physical functioning at 1 year. However, robot-assisted mitral valve repair had longer cardiopulmonary, aortic cross-clamp, and procedure times compared with all other surgical approaches.
Based on current evidence, robot-assisted mitral valve repair is comparable to other approaches for safety and early postoperative outcomes, despite being associated with longer operative times. Ideally, future studies will be randomized controlled trials that compare between robot-assisted surgery, conventional surgery, and other minimally surgery approaches focusing on hard clinical outcomes and patient-reported outcomes.
机器人辅助手术是修复二尖瓣的一种微创方法。本研究旨在评估其与传统胸骨切开术、部分胸骨切开术和右小开胸术相比的安全性和临床疗效。
按照 Cochrane 协作组指南,对比较机器人辅助二尖瓣修复术与传统胸骨切开术、部分胸骨切开术和右小开胸术的同行评审研究进行系统评价。在可能的情况下进行了荟萃分析。
搜索策略产生了 15 项主要研究,其中 12 项比较了机器人辅助与传统胸骨切开术,2 项比较了机器人辅助与部分胸骨切开术,6 项比较了机器人辅助与右小开胸术。总体证据质量较低,并且缺乏长期结果的数据。个别研究和汇总数据表明,机器人手术在卒中、肾衰竭、因出血再次手术和死亡率方面与传统胸骨切开术和其他微创手术方法的发生率相当。与传统胸骨切开术相比,机器人辅助二尖瓣修复术可降低房颤、重症监护病房和住院时间、疼痛、恢复正常活动的时间以及 1 年时的身体功能。然而,与所有其他手术方法相比,机器人辅助二尖瓣修复术的心肺转流、主动脉阻断和手术时间更长。
根据目前的证据,机器人辅助二尖瓣修复术在安全性和术后早期结果方面与其他方法相当,尽管手术时间较长。理想情况下,未来的研究将是随机对照试验,比较机器人辅助手术、传统手术和其他微创手术方法,重点关注硬临床结局和患者报告的结局。